In Vivo is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

First, More Vectors. Then, More Genes

Executive Summary

This month's merger agreement between financially sound, but scientifically narrow Cell Genesys Inc. (Foster City, CA)and the troubled, but technology-rich Somatix Therapy Corp. (Alameda, CA) [See Deal] was played to the investment community as an ideal match-up-a play for critical mass in the complex and clinically demanding field of gene therapy. Although the merits of size may seem self-evident, we may still ask, why is bigger better?
Advertisement

Topics

Related Companies

Advertisement
UsernamePublicRestriction

Register

IV000542

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel